User contributions

From WikiPathways

Search for contributions

 Show contributions of new accounts only
 IP Address or username: Namespace: all (Main) Talk User User talk WikiPathways WikiPathways talk Image Image talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk Thread Thread talk Summary Summary talk Pw Old Pw Old Talk Pathway Pathway Talk Wishlist Wishlist Talk Portal Portal Talk

From year (and earlier): From month (and earlier): all January February March April May June July August September October November December

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)

• 22:55, 27 February 2025 Homo sapiens:Cell cycle‎ (Modified description)
• 22:54, 27 February 2025 Homo sapiens:Translation inhibitors in chronically activated PDGFRA cells‎ (Modified description) (top)
• 22:53, 27 February 2025 Homo sapiens:Translation inhibitors in chronically activated PDGFRA cells‎ (Modified description)
• 22:53, 27 February 2025 Homo sapiens:MAPK signaling‎ (Modified description)
• 22:52, 27 February 2025 Homo sapiens:Hepatocyte growth factor receptor signaling‎ (Modified description) (top)
• 22:51, 27 February 2025 Homo sapiens:Microglia pathogen phagocytosis pathway‎ (Modified description) (top)
• 22:51, 27 February 2025 Homo sapiens:TYROBP causal network in microglia‎ (Modified description) (top)
• 22:50, 27 February 2025 Homo sapiens:Myometrial relaxation and contraction pathways‎ (Modified description) (top)
• 22:44, 27 February 2025 Homo sapiens:Amplification and expansion of oncogenic pathways as metastatic traits‎ (Modified description) (top)
• 22:43, 27 February 2025 Homo sapiens:Cancer pathways‎ (Modified description)
• 22:42, 27 February 2025 Homo sapiens:Integrated cancer pathway‎ (Modified description) (top)
• 22:11, 27 February 2025 Rattus norvegicus:Statin pathway‎ (Reverted to version '14:15, 16 May 2021' by <a href="/index.php/User:Khanspers" title="User:Khanspers">Khanspers</a>) (top)
• 22:10, 27 February 2025 Rattus norvegicus:Statin pathway‎ (Modified description)
• 22:08, 27 February 2025 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Modified description) (top)
• 22:06, 27 February 2025 Homo sapiens:Regulation of sister chromatid separation at the metaphase-anaphase transition‎ (Modified description) (top)
• 22:06, 27 February 2025 Homo sapiens:Non-small cell lung cancer‎ (Modified description)
• 22:03, 27 February 2025 Homo sapiens:Endometrial cancer‎ (Modified description) (top)
• 22:03, 27 February 2025 Homo sapiens:Pancreatic adenocarcinoma pathway‎ (Modified description) (top)
• 22:02, 27 February 2025 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Modified description)
• 22:01, 27 February 2025 Homo sapiens:MFAP5-mediated ovarian cancer cell motility and invasiveness‎ (Modified description)
• 22:00, 27 February 2025 Homo sapiens:Hepatitis B infection‎ (Modified description)
• 21:59, 27 February 2025 Homo sapiens:Head and neck squamous cell carcinoma‎ (Modified description)
• 21:58, 27 February 2025 Homo sapiens:EGFR tyrosine kinase inhibitor resistance‎ (Modified description)
• 23:52, 26 February 2025 Homo sapiens:lncRNA in canonical Wnt signaling and colorectal cancer‎ (Modified description) (top)
• 23:51, 26 February 2025 Homo sapiens:Mammary gland development: puberty - stage 2 of 4‎ (Modified description) (top)
• 23:49, 26 February 2025 Homo sapiens:Epithelial to mesenchymal transition in colorectal cancer‎ (Modified description)
• 23:49, 26 February 2025 Homo sapiens:Chromosomal and microsatellite instability in colorectal cancer ‎ (Modified description) (top)
• 23:47, 26 February 2025 Homo sapiens:MET in type 1 papillary renal cell carcinoma‎ (Modified description)
• 23:46, 26 February 2025 Homo sapiens:Clear cell renal cell carcinoma pathways‎ (Modified description)
• 23:45, 26 February 2025 Homo sapiens:Transcriptional activation by NRF2 in response to phytochemicals‎ (Modified description)
• 23:35, 26 February 2025 Homo sapiens:Interferon type I signaling‎ (Modified description) (top)
• 23:34, 26 February 2025 Homo sapiens:ErbB signaling‎ (Modified description)
• 23:34, 26 February 2025 Homo sapiens:PDGFR-beta pathway‎ (Modified description) (top)
• 22:41, 26 February 2025 Homo sapiens:Breast cancer pathway‎ (Modified description)
• 22:41, 26 February 2025 Homo sapiens:Breast cancer pathway‎ (Modified description)
• 22:37, 26 February 2025 Mus musculus:Oxidative stress and redox pathway‎ (Modified description)
• 22:32, 26 February 2025 Mus musculus:Glutathione and one-carbon metabolism‎ (Modified description) (top)
• 22:31, 26 February 2025 Mus musculus:Glutathione and one-carbon metabolism‎ (Modified description)
• 22:29, 26 February 2025 Homo sapiens:TGF-beta receptor signaling in skeletal dysplasias‎ (Modified description)
• 22:28, 26 February 2025 Homo sapiens:Endochondral ossification with skeletal dysplasias‎ (Modified description) (top)
• 22:26, 26 February 2025 Homo sapiens:DNA damage response (only ATM dependent)‎ (Modified description) (top)
• 22:22, 26 February 2025 Homo sapiens:ncRNAs in Wnt signaling in hepatocellular carcinoma‎ (Modified description) (top)
• 21:26, 26 February 2025 Bos taurus:Ketone bodies synthesis and degradation‎ (Modified description) (top)
• 21:26, 26 February 2025 Gallus gallus:Ketone bodies synthesis and degradation‎ (Modified description) (top)
• 21:26, 26 February 2025 Rattus norvegicus:Synthesis and degradation of ketone bodies‎ (Modified description) (top)
• 21:25, 26 February 2025 Canis familiaris:Ketone bodies synthesis and degradation‎ (Modified description) (top)
• 21:25, 26 February 2025 Caenorhabditis elegans:Ketone bodies synthesis and degradation‎ (Modified description) (top)
• 21:25, 26 February 2025 Drosophila melanogaster:Synthesis and degradation of ketone bodies‎ (Modified description) (top)
• 21:25, 26 February 2025 Pan troglodytes:Ketone bodies synthesis and degradation‎ (Modified description) (top)
• 21:24, 26 February 2025 Danio rerio:Ketone bodies synthesis and degradation‎ (Modified description) (top)

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)